Hopital Roger Salengro, CHU Lille
Lille, 59037, France
NCT Number: NCT04347928
In the present context, it seems necessary to try to describe as precisely as possible the physiological alterations due to COVID-19. From these observations, therapeutic proposals adapted to this new disease may then be developed, particularly in the symptomatic management of the critically ill patient. It therefore seems essential to rigorously study these modifications, as they have been studied in the past for ARDS.
The aim of this non-interventional study is to describe precisely the respiratory and hemodynamic changes induced by COVID-19 in mechanically ventilated patients
.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lille, 59037, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: during ICU stay, in the first 72 hours of mechanical ventilation initiation
Time frame: during ICU stay, in the first 72 hours of mechanical ventilation initiation
Evaluation of PaO2 variation between in a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)
Time frame: during ICU stay, in the first 72 hours of mechanical ventilation initiation
Evaluation of PaCO2 variation between in a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)
Time frame: during ICU stay, in the first 72 hours of mechanical ventilation initiation
Evaluation of cardiac output variation between a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)
University Hospital, Lille
Other
Acronym: PHYSIO-COVID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04402060
ARDS, Acute Lung Injury
Fresno, California, United States
View Trial DetailsNCT04371029
ARDS, COVID-19
Bordeaux, France
View Trial DetailsNCT04402879
ARDS, Acute Respiratory Distress Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT04335084
COVID, COVID-19
Ventura, California, United States
View Trial Details